Affinity chromatography for human Na+, K+-ATPase inhibitors in plasma and urine.
Semi-purified dog kidney Na+,K+-ATPase cross-linked with ovalbumin was used in batch-wise affinity chromatography for the detection of endogenous Na+,K+-ATPase inhibitor in human plasma and urine. Ammonium acetate 1 M washed off the endogenous inhibitor from the immobilized enzyme. The inhibitory activity of the eluate from hypertensive plasma and urine was significantly higher (p less than 0.0025, n = 5 and p less than 0.005, n = 6 respectively) than that of normotensive. This latter was correlated with the ability of plasma from the same subjects to compete with ouabain binding to erythrocytes. Plasma and urine extracts inhibited the activity of Na+, K+-ATPase in a dose-dependent manner as ouabain does and were shown to contain 3 or 4 active compounds by high pressure liquid chromatography. The activity of some of these compounds was lost after peptidase treatment. These data support the heterogeneity of endogenous inhibitors of Na+,K+-ATPase activity in plasma and urine.
Henning
G
G
Cloix
J F
JF
Wainer
I W
IW
Pernollet
M G
MG
Devynck
M A
MA
Meyer
P
P
D000818:Animals; D001667:Binding, Competitive; D002846:Chromatography, Affinity; D002851:Chromatography, High Pressure Liquid; D003429:Cross Reactions; D004077:Digoxin / Q000276:immunology; D004285:Dogs; D004800:Enzymes, Immobilized; D006801:Humans; D006868:Hydrolysis; D006973:Hypertension / Q000097:blood / Q000652:urine; D066298:In Vitro Techniques; D007668:Kidney / Q000201:enzymology; D010042:Ouabain / Q000494:pharmacology; D011955:Receptors, Drug / Q000378:metabolism; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors*
D004800:Enzymes, Immobilized; D011955:Receptors, Drug; C028996:cardiac glycoside receptors; D010042:Ouabain; D004077:Digoxin; D000254:Sodium-Potassium-Exchanging ATPase